Site Sponsors
  • Strem Chemicals - Nanomaterials for R&D
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Park Systems - Manufacturer of a complete range of AFM solutions
Posted in | Nanomedicine

New Report on Leaders in Smart Pills Technologies Market

Published on June 21, 2013 at 6:08 AM

Research and Markets has announced the addition of the "Smart Pills Technologies Market (2012-2017) (Diagnostic imaging, patient monitoring, drug delivery)" report to their offering.

Gastro-Intestinal (GI) disorders are becoming more prevalent in our day to day life owing to changing lifestyles, dietary habits and aging population. The effective therapeutics and sources or unknown causes of bleeding for some of the GI disorders are still an enigma to the medical industry due to lack of effective medical devices that reach the contours of small intestine. Although there are flexible endoscopes, they still cause discomfort to the patients due to insertion of wired tube into the body. The advancements in the field of medical science and technology and the emergence of micro and nanotechnology have paved the way for miniaturized wireless capsule endoscopes, also called as capsule endoscopes. These micro capsules can also be used for site-specific drug delivery and effective patient monitoring. This novel approach, enabled by Bio-MEMS is called as Smart Pills. This technology is not only comfortable for patients, but also enables the healthcare providers to take on-time remedical action effectively.

Based on the application, Smart Pills are categorized into:

Capsule endoscopy: Capsule endoscopes are used to diagnose GI disorders. There are some commercially available capsule endoscopes in the market. Improved reimbursement costs and easier regulatory approvals drive the growth of capsule endoscopy.

Smart Pills for drug delivery and patient monitoring are still emerging technologies. Factors such as site-specific drug delivery and effective disease monitoring are more likely to favour the adoption of smart pills by physicians and patients.

The report also categorizes smart pill technology based on geography and thoroughly analyzes the market adoption potential with respect to each region.

Companies Mentioned

  • Acamp (Canada)
  • Bio-Images Research Limited
  • Boston Scientific Corp
  • Capsovision, Inc.
  • Cerner Healthcare Private Limited
  • Fujifilm Holding Corporation
  • Ge Healthcare
  • Given Imaging Limited
  • Ibm Endicott
  • Karl Storz
  • Lloyd Pharmacy Limited
  • Mckesson Corporation
  • Medimetrics, Inc.
  • Medtronic, Inc
  • Novartis Pharma
  • Olympus Medical Technology
  • Pentax Medical Company
  • Philips Applied Technologies
  • Proteus Digital Health
  • Siemens Healthcare
  • Smart Pill, Inc.
  • Smith & Nehpew
  • Stryker Corporation
  • University Spin Off Hot Spots

For more information visit http://www.researchandmarkets.com/research/98v69x/smart_pills

Source: http://www.researchandmarkets.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit